SCHEMBL9979472

SCHEMBL9979472

CCOC(=O)Cn1ccc2cc(/C=C/c3cccc4c3CN(c3ccc(OC(F)(F)F)cc3)C4=O)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.34
NR5A1 Q13285 1/20 0.34
PPARD Q03181 4/20 0.33
PPARA Q07869 3/20 0.33
POLB P06746 2/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PPARG P37231 1/20 0.32
PLA2G4A P47712 1/20 0.32
TRPV1 Q8NER1 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
UGCG Q16739 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4D Q08499 1/20 0.32
SERPINE1 P05121 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9979531 0.91 PPARD (0.42) GCGRPPARDPPARAPPARGTRPV1
SCHEMBL9979508 0.85 PPARD (0.38) NR5A1PPARDPPARAMAPTPPARG
SCHEMBL9979654 0.85 PPARG (0.40) NR5A1PPARDPPARAPPARGUGCG
SCHEMBL9979703 0.79 L3MBTL1 (0.36) PPARDPPARAPOLBALDH1A1MAPT
SCHEMBL9979609 0.79 PPARA (0.41) PPARDPPARAPOLBPPARG
SCHEMBL9979610 0.79 PPARD (0.54) PPARDPPARAPPARGUGCGSERPINE1
SCHEMBL9979468 0.78 PPARD (0.45) PPARDPPARAPPARGUGCG
SCHEMBL9979611 0.75 PPARD (0.46) PPARDPPARAPPARG
SCHEMBL9979701 0.74 PPARG (0.49) PPARDPPARAPPARG
SCHEMBL9979660 0.72 PPARD (0.41) PPARDPPARAMAPTHTTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012081570-A1 LACTAM COMPOUND OR A SALT THEREOF, AND PPAR ACTIVATOR あすか製薬株式会社 (JP) 2012-06-21 WO disclosed